Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2022 Jan 6;21(1):136–142. doi: 10.1016/j.cgh.2021.12.047

Table 2:

AUROC with P values noted for the Training set of the Derivation cohort (n=299) and the validation cohort (n=94) compared to PHES CHE as the gold standard.

Derivation cohort training set (n=299) Total Time Off 1 Off1 through 2 Off1 through 3 Off through 4 Off1 through 5
AUROC 0.8831 0.8536 0.8773 0.8787 0.8864 0.8891
p-value vs. PHES ---- 0.0247 0.5812 0.6547 0.6719 0.4137
Validation cohort (n=94) Total Time Off 1 Off1 through 2 Off1 through 3 Off through 4 Off1 through 5
AUROC 0.8905 0.8929 0.8887 0.8893 0.8964 0.8905
p-value vs PHES ---- 0.9109 0.9266 0.9469 0.7243 1.0000

CHE: covert hepatic encephalopathy, PHES: psychometric hepatic encephalopathy score, HE: hepatic encephalopathy, AUROC: area under the receiver operating curve